The global market for Human Coagulation Factor VIII was estimated to be worth US$ 10230 million in 2023 and is forecast to a readjusted size of US$ 15770 million by 2030 with a CAGR of 6.3% during the forecast period 2024-2030

Human Coagulation Factor VIII - Market

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Coagulation Factor VIII, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Coagulation Factor VIII by region & country, by Type, and by Application.

The Human Coagulation Factor VIII market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coagulation Factor VIII.

Market Segmentation

Scope of Human Coagulation Factor VIII - Market Report

Report Metric	Details
Report Name	Human Coagulation Factor VIII - Market
Forecasted market size in 2030	US$ 15770 million
CAGR	6.3%
Forecasted years	2024 - 2030
Segment by Type:	Recombinant Factor VIII Plasma-derived Factor VIII
Segment by Application	Hemophilia A Spontanous / Trauma Surgical Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Coagulation Factor VIII in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Coagulation Factor VIII in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Human Coagulation Factor VIII - Market size in 2030?

Ans: The Human Coagulation Factor VIII - Market size in 2030 will be US$ 15770 million.

What is the market share of major companies in Human Coagulation Factor VIII - Market?

Ans: Global top five manufacturers hold a share about 80%.

What is the Human Coagulation Factor VIII - Market share by type?

Ans: In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%.

Who are the main players in the Human Coagulation Factor VIII - Market report?

Ans: The main players in the Human Coagulation Factor VIII - Market are Shire (Baxter), Bayer, CSL, Pfizer, Grifols, Biogen, Octapharma, NovoNordisk, Greencross, Kedrion, BPL, Hualan Bio, RAAS

What are the Application segmentation covered in the Human Coagulation Factor VIII - Market report?

Ans: The Applications covered in the Human Coagulation Factor VIII - Market report are Hemophilia A, Spontanous / Trauma, Surgical, Other

What are the Type segmentation covered in the Human Coagulation Factor VIII - Market report?

Ans: The Types covered in the Human Coagulation Factor VIII - Market report are Recombinant Factor VIII, Plasma-derived Factor VIII

1 Market Overview

1.1 Human Coagulation Factor VIII Product Introduction

1.2 Global Human Coagulation Factor VIII Market Size Forecast

1.2.1 Global Human Coagulation Factor VIII Sales Value (2019-2030)

1.2.2 Global Human Coagulation Factor VIII Sales Volume (2019-2030)

1.2.3 Global Human Coagulation Factor VIII Sales Price (2019-2030)

1.3 Human Coagulation Factor VIII Market Trends & Drivers

1.3.1 Human Coagulation Factor VIII Industry Trends

1.3.2 Human Coagulation Factor VIII Market Drivers & Opportunity

1.3.3 Human Coagulation Factor VIII Market Challenges

1.3.4 Human Coagulation Factor VIII Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Human Coagulation Factor VIII Players Revenue Ranking (2023)

2.2 Global Human Coagulation Factor VIII Revenue by Company (2019-2024)

2.3 Global Human Coagulation Factor VIII Players Sales Volume Ranking (2023)

2.4 Global Human Coagulation Factor VIII Sales Volume by Company Players (2019-2024)

2.5 Global Human Coagulation Factor VIII Average Price by Company (2019-2024)

2.6 Key Manufacturers Human Coagulation Factor VIII Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Human Coagulation Factor VIII Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Human Coagulation Factor VIII

2.9 Human Coagulation Factor VIII Market Competitive Analysis

2.9.1 Human Coagulation Factor VIII Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Human Coagulation Factor VIII Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Recombinant Factor VIII

3.1.2 Plasma-derived Factor VIII

3.2 Global Human Coagulation Factor VIII Sales Value by Type

3.2.1 Global Human Coagulation Factor VIII Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Human Coagulation Factor VIII Sales Value, by Type (2019-2030)

3.2.3 Global Human Coagulation Factor VIII Sales Value, by Type (%) (2019-2030)

3.3 Global Human Coagulation Factor VIII Sales Volume by Type

3.3.1 Global Human Coagulation Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Human Coagulation Factor VIII Sales Volume, by Type (2019-2030)

3.3.3 Global Human Coagulation Factor VIII Sales Volume, by Type (%) (2019-2030)

3.4 Global Human Coagulation Factor VIII Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hemophilia A

4.1.2 Spontanous / Trauma

4.1.3 Surgical

4.1.4 Other

4.2 Global Human Coagulation Factor VIII Sales Value by Application

4.2.1 Global Human Coagulation Factor VIII Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Human Coagulation Factor VIII Sales Value, by Application (2019-2030)

4.2.3 Global Human Coagulation Factor VIII Sales Value, by Application (%) (2019-2030)

4.3 Global Human Coagulation Factor VIII Sales Volume by Application

4.3.1 Global Human Coagulation Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Human Coagulation Factor VIII Sales Volume, by Application (2019-2030)

4.3.3 Global Human Coagulation Factor VIII Sales Volume, by Application (%) (2019-2030)

4.4 Global Human Coagulation Factor VIII Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Human Coagulation Factor VIII Sales Value by Region

5.1.1 Global Human Coagulation Factor VIII Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Human Coagulation Factor VIII Sales Value by Region (2019-2024)

5.1.3 Global Human Coagulation Factor VIII Sales Value by Region (2025-2030)

5.1.4 Global Human Coagulation Factor VIII Sales Value by Region (%), (2019-2030)

5.2 Global Human Coagulation Factor VIII Sales Volume by Region

5.2.1 Global Human Coagulation Factor VIII Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Human Coagulation Factor VIII Sales Volume by Region (2019-2024)

5.2.3 Global Human Coagulation Factor VIII Sales Volume by Region (2025-2030)

5.2.4 Global Human Coagulation Factor VIII Sales Volume by Region (%), (2019-2030)

5.3 Global Human Coagulation Factor VIII Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Human Coagulation Factor VIII Sales Value, 2019-2030

5.4.2 North America Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Human Coagulation Factor VIII Sales Value, 2019-2030

5.5.2 Europe Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Human Coagulation Factor VIII Sales Value, 2019-2030

5.6.2 Asia Pacific Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Human Coagulation Factor VIII Sales Value, 2019-2030

5.7.2 South America Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Human Coagulation Factor VIII Sales Value, 2019-2030

5.8.2 Middle East & Africa Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Human Coagulation Factor VIII Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Human Coagulation Factor VIII Sales Value

6.2.1 Key Countries/Regions Human Coagulation Factor VIII Sales Value, 2019-2030

6.2.2 Key Countries/Regions Human Coagulation Factor VIII Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Human Coagulation Factor VIII Sales Value, 2019-2030

6.3.2 United States Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Human Coagulation Factor VIII Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Human Coagulation Factor VIII Sales Value, 2019-2030

6.4.2 Europe Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Human Coagulation Factor VIII Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Human Coagulation Factor VIII Sales Value, 2019-2030

6.5.2 China Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

6.5.3 China Human Coagulation Factor VIII Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Human Coagulation Factor VIII Sales Value, 2019-2030

6.6.2 Japan Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Human Coagulation Factor VIII Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Human Coagulation Factor VIII Sales Value, 2019-2030

6.7.2 South Korea Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Human Coagulation Factor VIII Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Human Coagulation Factor VIII Sales Value, 2019-2030

6.8.2 Southeast Asia Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Human Coagulation Factor VIII Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Human Coagulation Factor VIII Sales Value, 2019-2030

6.9.2 India Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

6.9.3 India Human Coagulation Factor VIII Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Shire (Baxter)

7.1.1 Shire (Baxter) Company Information

7.1.2 Shire (Baxter) Introduction and Business Overview

7.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Offerings

7.1.5 Shire (Baxter) Recent Development

7.2 Bayer

7.2.1 Bayer Company Information

7.2.2 Bayer Introduction and Business Overview

7.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Bayer Human Coagulation Factor VIII Product Offerings

7.2.5 Bayer Recent Development

7.3 CSL

7.3.1 CSL Company Information

7.3.2 CSL Introduction and Business Overview

7.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.3.4 CSL Human Coagulation Factor VIII Product Offerings

7.3.5 CSL Recent Development

7.4 Pfizer

7.4.1 Pfizer Company Information

7.4.2 Pfizer Introduction and Business Overview

7.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Pfizer Human Coagulation Factor VIII Product Offerings

7.4.5 Pfizer Recent Development

7.5 Grifols

7.5.1 Grifols Company Information

7.5.2 Grifols Introduction and Business Overview

7.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Grifols Human Coagulation Factor VIII Product Offerings

7.5.5 Grifols Recent Development

7.6 Biogen

7.6.1 Biogen Company Information

7.6.2 Biogen Introduction and Business Overview

7.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Biogen Human Coagulation Factor VIII Product Offerings

7.6.5 Biogen Recent Development

7.7 Octapharma

7.7.1 Octapharma Company Information

7.7.2 Octapharma Introduction and Business Overview

7.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Octapharma Human Coagulation Factor VIII Product Offerings

7.7.5 Octapharma Recent Development

7.8 NovoNordisk

7.8.1 NovoNordisk Company Information

7.8.2 NovoNordisk Introduction and Business Overview

7.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.8.4 NovoNordisk Human Coagulation Factor VIII Product Offerings

7.8.5 NovoNordisk Recent Development

7.9 Greencross

7.9.1 Greencross Company Information

7.9.2 Greencross Introduction and Business Overview

7.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Greencross Human Coagulation Factor VIII Product Offerings

7.9.5 Greencross Recent Development

7.10 Kedrion

7.10.1 Kedrion Company Information

7.10.2 Kedrion Introduction and Business Overview

7.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Kedrion Human Coagulation Factor VIII Product Offerings

7.10.5 Kedrion Recent Development

7.11 BPL

7.11.1 BPL Company Information

7.11.2 BPL Introduction and Business Overview

7.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.11.4 BPL Human Coagulation Factor VIII Product Offerings

7.11.5 BPL Recent Development

7.12 Hualan Bio

7.12.1 Hualan Bio Company Information

7.12.2 Hualan Bio Introduction and Business Overview

7.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Hualan Bio Human Coagulation Factor VIII Product Offerings

7.12.5 Hualan Bio Recent Development

7.13 RAAS

7.13.1 RAAS Company Information

7.13.2 RAAS Introduction and Business Overview

7.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2019-2024)

7.13.4 RAAS Human Coagulation Factor VIII Product Offerings

7.13.5 RAAS Recent Development

8 Industry Chain Analysis

8.1 Human Coagulation Factor VIII Industrial Chain

8.2 Human Coagulation Factor VIII Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Human Coagulation Factor VIII Sales Model

8.5.2 Sales Channel

8.5.3 Human Coagulation Factor VIII Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Human Coagulation Factor VIII Market Trends

Table 2. Human Coagulation Factor VIII Market Drivers & Opportunity

Table 3. Human Coagulation Factor VIII Market Challenges

Table 4. Human Coagulation Factor VIII Market Restraints

Table 5. Global Human Coagulation Factor VIII Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Human Coagulation Factor VIII Revenue Market Share by Company (2019-2024)

Table 7. Global Human Coagulation Factor VIII Sales Volume by Company (2019-2024) & (K Bottles)

Table 8. Global Human Coagulation Factor VIII Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Human Coagulation Factor VIII Price by Company (2019-2024) & (USD/Bottle)

Table 10. Key Manufacturers Human Coagulation Factor VIII Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Human Coagulation Factor VIII Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Human Coagulation Factor VIII

Table 13. Global Human Coagulation Factor VIII Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Coagulation Factor VIII Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Human Coagulation Factor VIII Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Human Coagulation Factor VIII Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Human Coagulation Factor VIII Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Human Coagulation Factor VIII Sales Volume by Type: 2019 VS 2023 VS 2030 (K Bottles)

Table 22. Global Human Coagulation Factor VIII Sales Volume by Type (2019-2024) & (K Bottles)

Table 23. Global Human Coagulation Factor VIII Sales Volume by Type (2025-2030) & (K Bottles)

Table 24. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Human Coagulation Factor VIII Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Human Coagulation Factor VIII Price by Type (2019-2024) & (USD/Bottle)

Table 27. Global Human Coagulation Factor VIII Price by Type (2025-2030) & (USD/Bottle)

Table 28. Global Human Coagulation Factor VIII Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Human Coagulation Factor VIII Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Human Coagulation Factor VIII Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Human Coagulation Factor VIII Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Human Coagulation Factor VIII Sales Volume by Application: 2019 VS 2023 VS 2030 (K Bottles)

Table 34. Global Human Coagulation Factor VIII Sales Volume by Application (2019-2024) & (K Bottles)

Table 35. Global Human Coagulation Factor VIII Sales Volume by Application (2025-2030) & (K Bottles)

Table 36. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Human Coagulation Factor VIII Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Human Coagulation Factor VIII Price by Application (2019-2024) & (USD/Bottle)

Table 39. Global Human Coagulation Factor VIII Price by Application (2025-2030) & (USD/Bottle)

Table 40. Global Human Coagulation Factor VIII Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Human Coagulation Factor VIII Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Human Coagulation Factor VIII Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Human Coagulation Factor VIII Sales Value by Region (2019-2024) & (%)

Table 44. Global Human Coagulation Factor VIII Sales Value by Region (2025-2030) & (%)

Table 45. Global Human Coagulation Factor VIII Sales Volume by Region (K Bottles): 2019 VS 2023 VS 2030

Table 46. Global Human Coagulation Factor VIII Sales Volume by Region (2019-2024) & (K Bottles)

Table 47. Global Human Coagulation Factor VIII Sales Volume by Region (2025-2030) & (K Bottles)

Table 48. Global Human Coagulation Factor VIII Sales Volume by Region (2019-2024) & (%)

Table 49. Global Human Coagulation Factor VIII Sales Volume by Region (2025-2030) & (%)

Table 50. Global Human Coagulation Factor VIII Average Price by Region (2019-2024) & (USD/Bottle)

Table 51. Global Human Coagulation Factor VIII Average Price by Region (2025-2030) & (USD/Bottle)

Table 52. Key Countries/Regions Human Coagulation Factor VIII Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Human Coagulation Factor VIII Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Human Coagulation Factor VIII Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Human Coagulation Factor VIII Sales Volume, (2019-2024) & (K Bottles)

Table 56. Key Countries/Regions Human Coagulation Factor VIII Sales Volume, (2025-2030) & (K Bottles)

Table 57. Shire (Baxter) Company Information

Table 58. Shire (Baxter) Introduction and Business Overview

Table 59. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 60. Shire (Baxter) Human Coagulation Factor VIII Product Offerings

Table 61. Shire (Baxter) Recent Development

Table 62. Bayer Company Information

Table 63. Bayer Introduction and Business Overview

Table 64. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 65. Bayer Human Coagulation Factor VIII Product Offerings

Table 66. Bayer Recent Development

Table 67. CSL Company Information

Table 68. CSL Introduction and Business Overview

Table 69. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 70. CSL Human Coagulation Factor VIII Product Offerings

Table 71. CSL Recent Development

Table 72. Pfizer Company Information

Table 73. Pfizer Introduction and Business Overview

Table 74. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 75. Pfizer Human Coagulation Factor VIII Product Offerings

Table 76. Pfizer Recent Development

Table 77. Grifols Company Information

Table 78. Grifols Introduction and Business Overview

Table 79. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 80. Grifols Human Coagulation Factor VIII Product Offerings

Table 81. Grifols Recent Development

Table 82. Biogen Company Information

Table 83. Biogen Introduction and Business Overview

Table 84. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 85. Biogen Human Coagulation Factor VIII Product Offerings

Table 86. Biogen Recent Development

Table 87. Octapharma Company Information

Table 88. Octapharma Introduction and Business Overview

Table 89. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 90. Octapharma Human Coagulation Factor VIII Product Offerings

Table 91. Octapharma Recent Development

Table 92. NovoNordisk Company Information

Table 93. NovoNordisk Introduction and Business Overview

Table 94. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 95. NovoNordisk Human Coagulation Factor VIII Product Offerings

Table 96. NovoNordisk Recent Development

Table 97. Greencross Company Information

Table 98. Greencross Introduction and Business Overview

Table 99. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 100. Greencross Human Coagulation Factor VIII Product Offerings

Table 101. Greencross Recent Development

Table 102. Kedrion Company Information

Table 103. Kedrion Introduction and Business Overview

Table 104. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 105. Kedrion Human Coagulation Factor VIII Product Offerings

Table 106. Kedrion Recent Development

Table 107. BPL Company Information

Table 108. BPL Introduction and Business Overview

Table 109. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 110. BPL Human Coagulation Factor VIII Product Offerings

Table 111. BPL Recent Development

Table 112. Hualan Bio Company Information

Table 113. Hualan Bio Introduction and Business Overview

Table 114. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 115. Hualan Bio Human Coagulation Factor VIII Product Offerings

Table 116. Hualan Bio Recent Development

Table 117. RAAS Company Information

Table 118. RAAS Introduction and Business Overview

Table 119. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)

Table 120. RAAS Human Coagulation Factor VIII Product Offerings

Table 121. RAAS Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Human Coagulation Factor VIII Downstream Customers

Table 125. Human Coagulation Factor VIII Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Coagulation Factor VIII Product Picture

Figure 2. Global Human Coagulation Factor VIII Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Human Coagulation Factor VIII Sales Volume (2019-2030) & (K Bottles)

Figure 5. Global Human Coagulation Factor VIII Sales Price (2019-2030) & (USD/Bottle)

Figure 6. Human Coagulation Factor VIII Report Years Considered

Figure 7. Global Human Coagulation Factor VIII Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Human Coagulation Factor VIII Players Sales Volume Ranking (2023) & (K Bottles)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Coagulation Factor VIII Revenue in 2023

Figure 10. Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Recombinant Factor VIII Picture

Figure 12. Plasma-derived Factor VIII Picture

Figure 13. Global Human Coagulation Factor VIII Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Human Coagulation Factor VIII Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Human Coagulation Factor VIII Sales Volume by Type (2019 VS 2023 VS 2030) & (K Bottles)

Figure 16. Global Human Coagulation Factor VIII Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Human Coagulation Factor VIII Price by Type (2019-2030) & (USD/Bottle)

Figure 18. Product Picture of Hemophilia A

Figure 19. Product Picture of Spontanous / Trauma

Figure 20. Product Picture of Surgical

Figure 21. Product Picture of Other

Figure 22. Global Human Coagulation Factor VIII Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Human Coagulation Factor VIII Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Human Coagulation Factor VIII Sales Volume by Application (2019 VS 2023 VS 2030) & (K Bottles)

Figure 25. Global Human Coagulation Factor VIII Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Human Coagulation Factor VIII Price by Application (2019-2030) & (USD/Bottle)

Figure 27. North America Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Human Coagulation Factor VIII Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Human Coagulation Factor VIII Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Human Coagulation Factor VIII Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Human Coagulation Factor VIII Sales Volume (%), (2019-2030)

Figure 39. United States Human Coagulation Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Human Coagulation Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Human Coagulation Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Human Coagulation Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 45. China Human Coagulation Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 47. China Human Coagulation Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Human Coagulation Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Human Coagulation Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Human Coagulation Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Human Coagulation Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Human Coagulation Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Human Coagulation Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 57. India Human Coagulation Factor VIII Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Human Coagulation Factor VIII Sales Value by Type (%), 2023 VS 2030

Figure 59. India Human Coagulation Factor VIII Sales Value by Application (%), 2023 VS 2030

Figure 60. Human Coagulation Factor VIII Industrial Chain

Figure 61. Human Coagulation Factor VIII Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions